Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Supratentorial Brain Tumor Surgery × Sugammadex × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Stomach Neoplasms 2 Brain Neoplasms 2 beta-Thalassemia 1 Urologic Neoplasms 1 Supratentorial Brain Tumor Surgery 1 Strabismus 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Post-operative Residual Curarization 1 Obesity 1 Neuromuscular Blockade 1 Neoplasms 1 Myasthenia Gravis 1 Hepatoblastoma 1 Endobronchial Metastases 1 Emergence Delirium 1 Delayed Emergence from Anesthesia 1

Interventions

Sugammadex 1 Neostigmine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02944175 2018-10-19

Cerebral Oxygenation and Metabolism After Reversal Of Rocuronium: Comparison Between Sugammadex Versus Neostigmine

Mansoura University

Phase NA Unknown

Supratentorial Brain Tumor Surgery

Data powered by HemOnc (CC BY 4.0) Colophon ⚡